Related by context. All words. (Click for frequent words.) 59 recurrent metastatic ovarian cancer 57 MyVax R 55 modified glutathione analog 55 MEK inhibitors 55 unique alkylating agent 55 Panzem R NCD 55 XL# XL# XL# XL# 54 antiangiogenesis therapies 54 MyVax ® 54 Locteron ® 54 oncolytic virus therapies 54 Exelixis compounds 53 vaccines oncolytic virus 53 Canvaxin 53 Xcellerated T Cells 53 XL# anticancer compounds 53 otelixizumab 53 CTA# Injection 52 ZK EPO 52 HGS ETR1 mapatumumab 52 Insegia 52 CDK cyclin dependent 52 IMiDs 52 evaluating pirfenidone 52 trastuzumab DM1 T DM1 52 tomb Kurnia 52 CYT# potent vascular disrupting 52 zanolimumab 52 docetaxel Taxotere R 51 SinuNase 51 evaluating picoplatin 51 sapacitabine CYC# 51 registrational trial 51 Transdel TM 51 oral picoplatin 51 Amigal 51 FavId 51 oral prodrug 51 cancer immunotherapies 51 personalized immunotherapy 51 DPX Survivac 51 Glufosfamide 51 Neuradiab 51 IRX 2 51 TELINTRA 51 lenalidomide Revlimid R 51 OncoVEX GM CSF 51 Poly ICLC 51 DOS# 50 IMA# 50 Tectin TM 50 Chemophase 50 R#/MEM # 50 StromaCel Inc. 50 FOLFOX6 chemotherapy regimen 50 Xanafide 50 AzaSite Xtra 50 forodesine 50 eTag assays 50 product platforms AZX# 50 TELCYTA 50 CR# vcMMAE 50 MAXY alpha 50 commercialize deforolimus 50 anticancer therapies 50 oral ridaforolimus 50 NovaBay Aganocide compounds 50 delay bone metastases 50 velafermin 50 enzastaurin 50 AAG geldanamycin analog 50 L BLP# 50 PEG PAL 49 THR beta agonist 49 sorafenib tablets 49 Myocet 49 hematological cancers 49 gastrointestinal GVHD 49 Zemiva TM 49 ImmunoGen TAP technology 49 Vidaza ® 49 class mGluR5 inhibitor 49 Azedra 49 XL# XL# 49 OMAPRO 49 IoGen 49 Epothilones 49 investigational monoclonal antibody 49 pralatrexate injection folate analogue 49 alvespimycin 49 Archexin 49 HGS ETR2 49 IMC #B 49 ADVEXIN 49 Traficet EN 49 bafetinib 49 regenerative medicine therapies 49 novel therapeutic antibodies 49 ALN TTR 49 ONCONASE R 49 XmAb# 49 evaluating satraplatin 49 LE DT 49 ZFP Therapeutics 49 EVIZON TM squalamine lactate 49 Aurexis 49 Spokesman Mark Medvesky 49 ALN PCS 49 HCD# [002] 49 Elotuzumab 49 targeted radiotherapeutic 49 DAVANAT 49 lintuzumab 49 MEK inhibitor RDEA# 49 ThermoDox ® clinical 49 oral proteasome inhibitor 49 PLK1 SNALP 49 BiovaxID TM 49 oral isoform selective HDAC 49 pralatrexate 49 Marqibo 49 HGS# 49 TOCOSOL Paclitaxel 49 lintuzumab SGN 49 CoFactor 49 Kirkland Billings Mont 49 refractory chronic lymphocytic 49 Amplimexon 48 IAP inhibitor 48 ALN VSP 48 Zemiva TM Trofex TM 48 R sorafenib tablets 48 cintredekin besudotox 48 erlotinib Tarceva ® 48 Gemzar ® 48 synthetic retinoid 48 Poly ICR 48 Bezielle 48 Stimuvax 48 Dose Limiting Toxicity DLT 48 KNS # 48 NPC 1C 48 Zerenex 48 MKC# PP 48 AEG# 48 elotuzumab 48 subcutaneous formulation 48 forodesine hydrochloride 48 Cintredekin Besudotox 48 ADVEXIN p# therapy 48 Selective Electrochemical Tumor Ablation 48 aflibercept VEGF Trap 48 CD# CEA 48 paclitaxel Taxol ® 48 Carfilzomib 48 oral taxane 48 pegylated interferon alpha 2a 48 OvaRex R 48 Surfaxin LS 48 Asentar 48 CCX# 48 Allovectin 7 R 48 Cloretazine R VNP#M 48 ALIMTA 48 picoplatin 48 HERmark 48 trastuzumab Herceptin R 48 HGS ETR1 48 PNP inhibitor 48 MAXY G# 48 Azedra ™ 48 TKM PLK1 47 R Bortezomib 47 EGRIFTA TM 47 tiapamil 47 PANVAC VF 47 GVAX ® 47 PEG SN# 47 Ceflatonin 47 MGCD# [001] 47 ASONEP 47 SNALP 47 Ixempra 47 mocetinostat MGCD# 47 Viral Immunotherapy platform 47 refractory PTCL 47 PDX pralatrexate 47 Sulonex TM 47 VEGFR2 inhibitor 47 BLP# Liposome Vaccine 47 deforolimus 47 APOPTONE 47 PXD# 47 PROCHYMAL 47 SUCCEED trial 47 Anturol 47 custirsen 47 REOLYSIN R 47 omacetaxine 47 pradefovir 47 BiovaxID 47 metaglidasen 47 rNAPc2 47 vinorelbine tartrate 47 RG# [001] 47 lesinurad 47 HuMax CD4 47 MAGE A3 ASCI 47 GALNS 47 Fodosine 47 TRAIL receptor antibodies 47 sunitinib malate 47 orally administered inhibitor 47 MOZOBIL 47 Nexavar ® 47 CCX# B 47 Dacogen injection 47 S1P antibody 47 cetuximab Erbitux R 47 aflibercept 47 rALLy clinical trial 47 Urocidin TM 47 StemEx 47 Alocrest 47 AzaSite Plus 47 FOLOTYN 47 Allovectin 7 ® 47 Locteron 47 celgosivir 47 Onco TCS 47 hypoxia activated prodrug 47 vosaroxin 47 Allovectin 7 47 CORLUX CORT # 47 GRNVAC1 47 galiximab 46 valopicitabine 46 Panzem 46 glufosfamide 46 refractory indolent non 46 Panzem R 46 hormone LHRH antagonist 46 OMP #R# 46 HuMax EGFr 46 Fx #A 46 XL# XL# XL# 46 docetaxel chemotherapy 46 agonistic human 46 Defonseca admission 46 OncoGel 46 DAVANAT R 46 refractory Hodgkin lymphoma 46 nucleoside tide 46 GVAX Pancreas Vaccine 46 investigational immunotherapy 46 TNFerade 46 selective immunoproteasome inhibitor 46 Azedra TM 46 refractory metastatic 46 ENMD # 46 forodesine HCl 46 Metastatic Melanoma 46 PS# [001] 46 Phase #b/#a clinical 46 REOLYSIN ® 46 PAC G#P 46 PI3K/Akt pathway inhibitor 46 ALN TTR# 46 MBP# [001] 46 autoimmune indications 46 CD4 monoclonal antibody 46 panitumumab 46 Maximum Tolerated Dose MTD 46 Symadex 46 CEQ# 46 Virulizin ® 46 Phase III Pivotal 46 Curaxin CBLC# 46 maximally tolerated dose 46 Greineder lawyers 46 BRAF inhibitor 46 entinostat 46 Fludara 46 non nucleoside HCV 46 investigational therapies 46 #D#C# 46 VEGF Trap 46 EFAPROXYN 46 Personalized Immunotherapy 46 lumiliximab 46 ZEVALIN ® 46 tezampanel NGX# 46 Financial Institutions FISI 46 evaluating Xcytrin 46 YONDELIS 46 Virosome Biologicals 46 Aflibercept 46 neratinib 46 novel VDA molecule 46 Aurora kinase inhibitor 46 Caminiti Marriott 46 FOLOTYN ® 46 Azedra TM Onalta TM 46 HCV protease inhibitor 46 rxRNA 46 Vandetanib 46 Sudhir Agrawal D.Phil 46 CORT # 46 tubulin inhibitor 46 Sym# 46 JAK inhibitor 46 Ketotransdel 46 anticancer compounds 46 Targretin 46 GATTEX TM 46 anti CD# antibodies 46 ongoing Phase IIIb 46 GED aPC 46 LymphoStat B TM 46 tezampanel 46 DAVANAT ® 46 advanced carcinoid 46 Restanza 46 non nucleoside polymerase 46 MEK Inhibitor 46 Roxanne Osler recalled 46 ONTAK 46 tamibarotene 46 Solazed TM 45 PrevOnco 45 intravesical infusion therapy 45 Targeted Chemotherapy 45 Attorney Carmen Durso 45 RGB # 45 StemEx R 45 Tarvacin TM 45 bevacizumab Avastin ® 45 PNT# 45 orBec R 45 Genasense ® 45 ganetespib 45 cediranib 45 oncolytic viruses 45 HER2 positive metastatic breast 45 farletuzumab 45 adecatumumab 45 PrevOnco ™ 45 OHR/AVR# 45 HspE7 45 Ixabepilone 45 palifosfamide 45 L MTP PE 45 Pralatrexate 45 candidates bavituximab 45 Tyrima 45 candidate AQ4N 45 PROVENGE 45 lapatinib Tykerb 45 platinum chemotherapeutic 45 Kosan dependence 45 mertansine 45 mifamurtide 45 Prochymal 45 CD# monoclonal antibody 45 TLK# 45 Curaxin 45 TLR9 agonists 45 motesanib 45 GVAX immunotherapy 45 sorafenib Nexavar ® 45 PRT# 45 MAbs targeting 45 ® bortezomib 45 PEGPH# 45 TACI Ig 45 Romidepsin 45 ApoB SNALP 45 KRN# 45 Bioral Amphotericin B 45 low dose cytarabine 45 BRIM2 45 ASA# 45 optimal dosing 45 telomerase therapeutic 45 Chimigen TM 45 Anthim 45 tivozanib 45 Genasense R 45 CD# expressing 45 Fludara ® 45 Synavive 45 hematological malignancies 45 Ceplene/IL-2 45 IgG1 monoclonal antibody 45 bardoxolone 45 PRTX 45 PolyActive ® 45 Kobagaya attorneys 45 alpha folate receptor 45 LEUKINE 45 AZD# 45 Xeloda ® 45 ponatinib 45 Xcytrin 45 drug conjugate 45 docetaxel Taxotere ® 45 obatoclax 45 Stimuvax R 45 Tovaxin 45 Valortim 45 ADVEXIN clinical 45 eniluracil 45 Hepatocellular Carcinoma HCC 45 brentuximab vedotin 45 radiolabeled TM# 45 CBLC# 45 investigational humanized monoclonal antibody 45 oral deforolimus 45 encapsulates siRNAs 45 OncoVEX 45 ISTODAX 45 Daclizumab 45 Kamada AAT 45 peginesatide 45 cilengitide 45 Dacogen 45 Troxatyl 45 Folotyn 45 Cloretazine ® 45 dependent kinase inhibitor 44 sarcoma melanoma 44 pancreatic prostate 44 LEP ETU 44 Etubics 44 antibody MAb 44 ZYBRESTAT fosbretabulin 44 confirmatory Phase III 44 BCX# 44 MEND CABG II 44 ELACYT 44 Randomized Double blind 44 Delcath PHP System 44 Phase Ib clinical trials 44 cytotoxic agents 44 IAP inhibitors 44 telaprevir VX 44 Perifosine 44 Trofex 44 Guanilib 44 Tamibarotene 44 Guandique gwahn DEE' kay 44 Panzem NCD 44 Tesetaxel 44 thymalfasin 44 novel topoisomerase 44 A. Zauzmer 44 BrachySil 44 REOLYSIN 44 Protexia ® 44 chemotherapeutic drugs 44 SNALP technology 44 MT# MEDI 44 vernakalant oral 44 TORISEL 44 Lymphoseek ® 44 liposomal formulation 44 IL# PE#QQR 44 interferon gamma 1b 44 Leukine ® 44 anti CD3 monoclonal 44 albinterferon alfa 2b 44 velafermin belinostat 44 ATryn R 44 Hedgehog Pathway Inhibitor 44 TNFerade TM 44 TRISENOX ® 44 oral antiviral 44 vorinostat 44 Clolar ® 44 JAK1 44 alfa 2a 44 Lovaxin C 44 UVIDEM 44 SAR# [004] 44 DCVax R Brain 44 ridaforolimus 44 Aplidin 44 relapsed refractory multiple myeloma 44 BEMA TM Fentanyl 44 ACAPODENE TM 44 PSMA ADC 44 Annamycin 44 registrational 44 Aztreonam lysine 44 DermaVir Patch 44 PRECISE Trial 44 Vitaxin 44 Aurora kinase 44 metastatic HRPC 44 Civacir 44 Genasense 44 GVAX R 44 refractory CLL 44 Protexia R 44 recurrent NSCLC 44 subcutaneous Herceptin 44 DCVax ® 44 Homspera 44 Vidaza 44 ZEVALIN 44 Litx 44 ISIS # 44 Phase #/#a trial 44 GTC recombinant human 44 humanized anti 44 Brentuximab Vedotin SGN 44 NEUMUNE 44 tanespimycin 44 pertuzumab 44 imetelstat 44 polymer platinate 44 Nanobody 44 evaluating tivozanib 44 SECTA therapy 44 PLX PAD 44 Lux Bioscience 44 BiTE antibody 43 isavuconazole 43 Hsp# Inhibitor 43 elacytarabine 43 pemetrexed Alimta 43 clofarabine 43 Atiprimod 43 hematologic malignancies 43 TRO# 43 angioedema indications 43 PEG Interferon lambda 43 systemic RNAi therapeutic 43 huC# DM4 43 liposome formulations 43 carcinoma HCC 43 phase IIb clinical 43 Intravenous CP 43 Phase IIb III 43 Lenocta TM 43 ADI PEG 43 sapacitabine 43 INCB# [001] 43 Omacetaxine 43 Kevetrin ™ 43 solid tumors 43 Onyx Pharmaceuticals Announces 43 Radilex 43 Indaflex TM 43 DCVax ® Brain 43 Thad Altman Viera 43 CRMD# 43 imetelstat GRN#L 43 CRLX# 43 ACTEMRA TM 43 Nicole Onetto MD 43 BENLYSTA ® 43 Onalta 43 2 methoxyestradiol 43 L DOS# 43 Bicifadine 43 antisense drug 43 anticancer compound 43 RECOTHROM 43 Neuradiab TM 43 decitabine 43 mitogen activated ERK kinase 43 Voraxaze ™ 43 Immunotherapeutic 43 oral Azacitidine 43 Celator 43 TransVax ™ 43 oncology therapeutics 43 anticancer therapy 43 oncology indications 43 AKT inhibitor 43 ATL# [001] 43 adecatumumab MT# 43 IMC A# 43 lorvotuzumab mertansine 43 AVN# [001] 43 GATTEX ® 43 ThermoDox R 43 Abiraterone acetate 43 Oncaspar 43 dacetuzumab 43 Hollis Eden 43 tyrosine kinase inhibitor 43 immunotherapeutic 43 phenoxodiol 43 initiate Phase 1b 43 AQ4N 43 OPAXIO 43 Walter Rothgery 43 EndoTAG TM -1 43 Sapacitabine 43 nab paclitaxel 43 Valortim ® 43 CA4P 43 tremelimumab 43 Trofex TM 43 tesmilifene 43 RITUXAN 43 StaphVAX R 43 UPLYSO 43 Genasense ® oblimersen 43 CINTREDEKIN BESUDOTOX 43 Richard Heene bristled 43 saline placebo 43 orBec ® 43 Exherin TM 43 ofatumumab 43 Topical Interferon Alpha 2b 43 favorable pharmacokinetic profile 43 Proellex TM 43 OvaRex ® MAb 43 Vicinium TM 43 nonclinical studies 43 pixantrone 43 dacetuzumab SGN 43 recurrent malignant gliomas 43 carfilzomib 43 Multikine 42 ALN HPN 42 mapatumumab 42 blinatumomab 42 Gliadel Wafer 42 cancer neuroendocrine tumor 42 CD# antibody [001] 42 NGX# 42 GRN#L 42 cleavable linker 42 TYKERB 42 satraplatin 42 cutaneous T cell 42 Proxinium TM 42 radiation sensitizer 42 polymerase inhibitors 42 Femprox ® 42 ARRY # 42 APF# 42 nimotuzumab 42 afatinib 42 oral JAK#/JAK# inhibitor 42 CCR5 mAb 42 MGCD# MGCD# [001] 42 CIMZIA TM 42 romidepsin 42 Hyphanox 42 Leukine 42 Virulizin R 42 Golimumab 42 tolerability pharmacokinetics 42 multiple myeloma MM 42 Exelixis XL# 42 AVE# 42 IMGN# 42 5 Fluorouracil 42 sodium thiosulfate STS 42 myeloproliferative disorders 42 CUDC 42 Jeffrey Monzo 42 ZADAXIN 42 NP2 Enkephalin 42 voreloxin 42 BrachySil TM 42 metastatic GIST 42 Lenocta 42 Neumune 42 omega interferon 42 MGN# 42 confirmatory Phase 3 42 Bortezomib 42 lymphoma CTCL 42 Initiate Phase II 42 anticancer agents 42 eculizumab 42 Phase 1b trial 42 Combination REOLYSIN R 42 Chemokine Therapeutics 42 Aerosurf 42 alemtuzumab MS 42 AP# [003] 42 AeroLEF TM 42 Vidovics 42 talactoferrin 42 fund BioSante LibiGel 42 Nektar pulmonary 42 HDAC Inhibitor 42 ONCASPAR 42 pharmacodynamic markers 42 Voreloxin 42 EOquin TM 42 Viprinex 42 IIa trial 42 Dose Escalation 42 GATTEX 42 ANYARA 42 TRISENOX 42 hyaluronidase rHuPH# 42 Mukul Rohatgi lawyer 42 relapsed multiple myeloma 42 CAMPATH 41 Thelin TM 41 Piyush Chandra 41 #I TM# 41 belinostat 41 Fualaau Letourneau 41 ISTODAX ® 41 OMP #M# 41 MGd 41 stable nucleic acid 41 NeoLipid R 41 PROSTVAC ® 41 ON #.Na 41 Mitoxantrone 41 XL# [003] 41 MDV# 41 spokeswoman Liana Shlyaposhnikova 41 veltuzumab 41 Aeroquin 41 RhuDex ® 41 axitinib 41 shelter Mridha 41 LibiGel Phase III 41 ixabepilone 41 EGFR expressing mCRC 41 cytarabine 41 Alpharadin 41 LY# [003] 41 JAK2 inhibitor 41 TREANDA 41 MEK inhibitor 41 drug GAP #B# 41 COPREXA 41 Neulasta ® 41 Advaxis Phase 41 torezolid phosphate 41 CYC# 41 gone Diang 41 perifosine 41 Phase III clinical 41 vandetanib 41 Taxotere ® 41 chemotherapeutic agents 41 ARIKACE 41 ritonavir boosted danoprevir 41 Tivozanib 41 safety tolerability pharmacokinetics 41 Frank Mondano Shanley 41 Tarceva TM 41 gemcitabine chemotherapy 41 RNAi Therapeutic 41 GRN# 41 telomerase inhibitor 41 Phase 2a clinical trials 41 Azixa 41 sd rxRNA compounds 41 Amrubicin 41 ZYBRESTAT 41 Phase 2b study 41 chemotherapeutic drug 41 SPRYCEL 41 ALN RSV# 41 limiting toxicity DLT 41 MAbs 41 amrubicin 41 Circ Pharma 41 doublet chemotherapy 41 Cotara 41 ENMD 41 depsipeptide 41 Apaziquone 41 Malignant Glioma 40 microsphere therapy 40 phase IIa clinical 40 ara C 40 Vivecon 40 refractory cutaneous T 40 pegloticase 40 telomerase inhibitor drug 40 EGFR HER2 40 docetaxel Taxotere 40 Viramidine 40 ThermoDox ® 40 A. Pizzuto 40 Samuel Braverman 40 Milatuzumab 40 Phase 2a trial 40 novel peptide 40 rituximab 40 EOquin 40 oral mTOR inhibitor 40 P. Naftalis 40 elesclomol 40 James Lobsenz Witt 40 indibulin 40 Catarina Gonzales 40 tesetaxel 40 Belinostat 40 Phase Ib 40 cetuximab Erbitux 40 ANA# 40 Li Fraumeni Syndrome 40 NEUVENGE 40 preclinical toxicology 40 GLP toxicology studies 40 talabostat 40 olaparib 40 Marilyn Bednarski 40 ISA# [002] 40 ongoing Phase 1b 40 Budesonide MMX 40 Thiovir 40 glioblastoma multiforme GBM 40 adjuvant GIST 40 RH1 40 paclitaxel cisplatin 40 tiuxetan 40 friend Kathye Herrera 40 advice Scaperotti 40 gefitinib 40 BNC# 40 Jevtana 40 taribavirin 40 carboplatin paclitaxel 40 R bortezomib 40 refractory multiple myeloma 40 Allovectin 7 r 40 Reolysin 40 Phase IIb clinical trials 40 TASKi2 40 Tumour Vascular Disrupting Agent 40 Phase 2b trial 40 PRX # 40 ORE# 40 refractory AML 40 Phase IIa clinical trials 40 Zevalin R Ibritumomab 40 Imprime PGG 40 initiated Phase 1b 40 Max Ludy 40 isoform selective 40 Edwina Moncur 40 IMP# 40 teduglutide 40 Antonio Ponvert III 40 OXi# 40 MGCD# MGCD# [002] 40 Phase Ib II 40 Cloretazine R 40 APPRAISE 40 Phase III confirmatory 40 Aptivus ® 40 ProLindac 40 Harry Palmin President 40 histone deacetylase inhibitor 40 Eitan Lehman 40 Revlimid lenalidomide 40 MGCD# [002] 40 vismodegib 40 TAFA# 40 palifosfamide Zymafos TM 40 cytotoxics 40 INCB# [002] 40 AGGRASTAT ® 40 Interferon alpha 2b 39 Phase #b/#a 39 mitomycin 39 TASKi3 39 NVA# 39 BEMA Buprenorphine 39 APD# 39 ERBITUX 39 phase IIb III 39 ZACTIMA 39 gemcitabine cisplatin 39 cMET 39 phase Ib 39 Ontak 39 MVA BN 39 Avicena 39 mocetinostat 39 Provecta 39 Bernardo Teixeira 39 RNAi therapeutic 39 Phase Ib clinical 39 demonstrated antitumor activity 39 Darinaparsin 39 G#DT 39 ABRAXANE 39 metastatic castrate resistant 39 Intarcia 39 CBLB# 39 Bridgette Trice Devyn Bolton 39 Nexavar 39 cisplatin gemcitabine 39 GAP #B# 39 consent Dobrynin 39 NB S# 39 Phase Ib study 39 Tarvacin 39 dismiss al Marri 39 multicenter Phase II 39 endlessly litigated 39 reconcile Jenny Sanford 39 Ms Sebire 39 anticancer agent 39 Rosie McNichol 39 novel anticancer 39 dose escalation 39 PF # [001] 39 eritoran 39 suspect Donald Heathfield 39 Terry MacFadyen 39 huN# DM1 39 temozolomide 39 Triapine R 39 Phase 2b clinical 38 SparVax TM 38 Lavetta Sites 38 hero Kastigar 38 Garrocho referred questions 38 platinum refractory 38 Garcia Pliego 38 docetaxel 38 fledgling leftist Sandinista 38 Pivotal Phase III 38 CYT# 38 plus dexamethasone 38 Protectan CBLB# 38 Alnylam #x# 38 GVAX 38 Michak 38 Zybrestat 38 cancer immunotherapy 38 Phase 1b 38 EarthJustice representing 38 RiVax ™ 38 RAV# 38 Van der Straaten 38 BCIRG 38 M Vax 38 Ramoplanin 38 bortezomib Velcade R 38 tgAAC# 38 intranasal delivery 38 lawyer TR Paulding 38 dose cohorts 38 dose escalation trial 38 hA# 38 CLORETAZINE TM VNP#M 38 bavituximab 38 Pfizer Oncology 38 gemcitabine 38 Attorney Howard Weitzman 38 dose escalation Phase 38 metastatic melanoma 38 zalutumumab 38 ILLUMINATE 38 Hsp# inhibitor 38 mother Lia Boldt 38 AGGRASTAT R 38 immunosuppressive compound 38 Richard Preira 38 attorney Roberto Stanziale 38 FOLFIRI chemotherapy 38 subcutaneous SC 38 compound AEZS 38 Listeria vaccine 38 Todzo 38 Fanburg 38 T DM1 37 estranged mother Vergie 37 pivotal Phase III 37 Lloyd Kirschbaum 37 Edgley Cremation Services 37 PRECISE trial 37 randomized Phase 37 fallopian tube cancers 37 GMX# 37 COU AA 37 RNAi therapeutics 37 carboplatin 37 Exherin 37 Judge Pallmeyer 37 father Redha Hassan 37 Doretha H. 37 BioNumerik 37 Zevalin 37 slaying Avey 37 phase IIb 37 G. Morvillo 37 prostate cancer AIPC